首页> 美国卫生研究院文献>Experimental Molecular Medicine >mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury
【2h】

mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury

机译:自噬诱导外伤性视神经损伤后mTORC2激活通过Akt信号传导保护视网膜神经节细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traumatic optic neuropathy is an injury to the optic nerve that leads to vision loss. Autophagy is vital for cell survival and cell death in central nervous system injury, but the role of autophagy in traumatic optic nerve injury remains uncertain. Optic nerve crush is a robust model of traumatic optic nerve injury. p62 siRNA and rapamycin are autophagy inducers and have different neuroprotective effects in the central nervous system. In this study, p62 and rapamycin induced autophagy, but only p62 siRNA treatment provided a favorable protective effect in visual function and retinal ganglion cell (RGC) survival. Moreover, the number of macrophages at the optic nerve lesion site was lower in the p62-siRNA-treated group than in the other groups. p62 siRNA induced more M2 macrophage polarization than rapamycin did. Rapamycin inhibited both mTORC1 and mTORC2 activation, whereas p62 siRNA inhibited only mTORC1 activation and maintained mTORC2 and Akt activation. Inhibition of mTORC2-induced Akt activation resulted in blood–optic nerve barrier disruption. Combined treatment with rapamycin and the mTORC2 activator SC79 improved RGC survival. Overall, our findings suggest that mTORC2 activation after autophagy induction is necessary for the neuroprotection of RGCs in traumatic optic nerve injury and may lead to new clinical applications.
机译:创伤性视神经病变是导致视力丧失的视神经损伤。自噬对于中枢神经系统损伤中的细胞存活和细胞死亡至关重要,但是自噬在外伤性视神经损伤中的作用仍然不确定。视神经挤压是创伤性视神经损伤的可靠模型。 p62 siRNA和雷帕霉素是自噬诱导剂,在中枢神经系统中具有不同的神经保护作用。在这项研究中,p62和雷帕霉素诱导自噬,但只有p62 siRNA治疗在视觉功能和视网膜神经节细胞(RGC)存活中提供了良好的保护作用。此外,在p62-siRNA治疗组中,视神经病变部位的巨噬细胞数量比其他组要少。与雷帕霉素相比,p62 siRNA诱导更多的M2巨噬细胞极化。雷帕霉素同时抑制mTORC1和mTORC2激活,而p62 siRNA仅抑制mTORC1激活并维持mTORC2和Akt激活。抑制mTORC2诱导的Akt激活导致血-视神经屏障的破坏。雷帕霉素和mTORC2激活剂SC79的联合治疗可改善RGC生存率。总体而言,我们的发现表明自噬诱导后mTORC2激活对于外伤性视神经损伤中RGC的神经保护是必要的,并且可能导致新的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号